Hyperlipidemia Trials in Bethesda, United States
Conditions / Hyperlipidemia / Bethesda, United States
Hyperlipidemia has been the subject of sustained clinical investigation across multiple research sites.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01375777 | Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels | COMPLETED | PHASE2 |
| NCT02100514 | Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events | COMPLETED | PHASE3 |
| NCT02262832 | Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02262806 | Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy | ACTIVE_NOT_RECRUITING | — |
| NCT00001142 | Metabolism and Body Shape of Healthy Children and Children With Chronic Infections | COMPLETED | — |
| NCT00267280 | A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031). | TERMINATED | PHASE3 |
| NCT00382564 | Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease | COMPLETED | — |
| NCT00138762 | A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol | COMPLETED | PHASE3 |
| NCT01606930 | A Pilot Study to Improve Patient-Doctor Communication | COMPLETED | NA |
| NCT01763827 | Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2 | COMPLETED | PHASE3 |